Holocene Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
64,322
+52,343
| +437% | +$932K | ﹤0.01% | 624 |
|
|
2025
Q1 | $213K | Sell |
11,979
-27,963
| -70% | -$498K | ﹤0.01% | 710 |
|
|
2024
Q4 | $1.19M | Sell |
39,942
-34,306
| -46% | -$1.02M | ﹤0.01% | 636 |
|
|
2024
Q3 | $1.16M | Buy |
74,248
+22,276
| +43% | +$348K | ﹤0.01% | 600 |
|
|
2024
Q2 | $890K | Sell |
51,972
-117,445
| -69% | -$2.01M | ﹤0.01% | 609 |
|
|
2024
Q1 | $2.65M | Buy |
169,417
+3,919
| +2% | +$61.3K | 0.01% | 535 |
|
|
2023
Q4 | $2.47M | Sell |
165,498
-77,340
| -32% | -$1.15M | 0.01% | 494 |
|
|
2023
Q3 | $3.92M | Buy |
+242,838
| New | +$3.92M | 0.02% | 421 |
|
|
2022
Q2 | – | Sell |
-21,202
| Closed | -$1.76M | – | 938 |
|
|
2022
Q1 | $1.76M | Buy |
+21,202
| New | +$1.76M | 0.01% | 555 |
|
|
2020
Q4 | – | Sell |
-5,793
| Closed | -$645K | – | 793 |
|
|
2020
Q3 | $645K | Buy |
+5,793
| New | +$645K | ﹤0.01% | 526 |
|